Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CIPLA vs ALEMBIC - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CIPLA ALEMBIC CIPLA/
ALEMBIC
 
P/E (TTM) x 32.2 28.2 114.5% View Chart
P/BV x 5.2 1.0 500.0% View Chart
Dividend Yield % 0.6 2.6 21.6%  

Financials

 CIPLA   ALEMBIC
EQUITY SHARE DATA
    CIPLA
Mar-23
ALEMBIC
Mar-23
CIPLA/
ALEMBIC
5-Yr Chart
Click to enlarge
High Rs1,18587 1,362.3%   
Low Rs85256 1,534.6%   
Sales per share (Unadj.) Rs281.95.0 5,688.8%  
Earnings per share (Unadj.) Rs35.13.1 1,118.9%  
Cash flow per share (Unadj.) Rs49.73.4 1,459.7%  
Dividends per share (Unadj.) Rs8.502.20 386.4%  
Avg Dividend yield %0.83.1 27.0%  
Book value per share (Unadj.) Rs289.280.9 357.4%  
Shares outstanding (eoy) m807.15256.78 314.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.614.4 25.1%   
Avg P/E ratio x29.022.7 127.7%  
P/CF ratio (eoy) x20.521.0 97.9%  
Price / Book Value ratio x3.50.9 399.9%  
Dividend payout %24.270.1 34.5%   
Avg Mkt Cap Rs m822,16418,298 4,493.1%   
No. of employees `000NANA-   
Total wages/salary Rs m38,301240 15,930.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m227,5311,272 17,881.8%  
Other income Rs m5,121643 796.9%   
Total revenues Rs m232,6531,915 12,148.6%   
Gross profit Rs m48,079297 16,175.0%  
Depreciation Rs m11,72167 17,434.3%   
Interest Rs m1,0955 23,557.0%   
Profit before tax Rs m40,384868 4,652.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m12,02962 19,466.9%   
Profit after tax Rs m28,355806 3,517.1%  
Gross profit margin %21.123.4 90.5%  
Effective tax rate %29.87.1 418.4%   
Net profit margin %12.563.4 19.7%  
BALANCE SHEET DATA
Current assets Rs m168,0511,721 9,762.7%   
Current liabilities Rs m50,333838 6,005.5%   
Net working cap to sales %51.769.4 74.5%  
Current ratio x3.32.1 162.6%  
Inventory Days Days735,038 1.5%  
Debtors Days Days7673 1.0%  
Net fixed assets Rs m117,31820,324 577.2%   
Share capital Rs m1,614514 314.3%   
"Free" reserves Rs m231,84520,267 1,144.0%   
Net worth Rs m233,46020,780 1,123.5%   
Long term debt Rs m00-   
Total assets Rs m290,06722,046 1,315.7%  
Interest coverage x37.9187.7 20.2%   
Debt to equity ratio x00-  
Sales to assets ratio x0.80.1 1,359.1%   
Return on assets %10.23.7 276.0%  
Return on equity %12.13.9 313.1%  
Return on capital %17.84.2 423.1%  
Exports to sales %22.61.2 1,837.1%   
Imports to sales %8.92.4 377.8%   
Exports (fob) Rs m51,51616 328,545.9%   
Imports (cif) Rs m20,20230 67,564.5%   
Fx inflow Rs m64,28216 409,959.8%   
Fx outflow Rs m20,20230 67,564.5%   
Net fx Rs m44,080-14 -309,985.2%   
CASH FLOW
From Operations Rs m32,377389 8,333.1%  
From Investments Rs m-23,88573 -32,737.3%  
From Financial Activity Rs m-9,583-464 2,065.8%  
Net Cashflow Rs m-968-2 40,325.0%  

Share Holding

Indian Promoters % 13.4 70.9 18.9%  
Foreign collaborators % 20.0 0.0 -  
Indian inst/Mut Fund % 50.0 0.9 5,318.1%  
FIIs % 25.7 0.9 2,891.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 66.5 29.1 228.5%  
Shareholders   425,731 94,012 452.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CIPLA With:   DIVIS LABORATORIES    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on Cipla vs ALEMBIC

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Cipla vs ALEMBIC Share Price Performance

Period Cipla ALEMBIC S&P BSE HEALTHCARE
1-Day 1.94% 4.34% 1.18%
1-Month 1.25% -14.48% -0.75%
1-Year 68.02% 48.73% 61.82%
3-Year CAGR 22.53% -6.26% 18.16%
5-Year CAGR 23.24% 14.97% 19.79%

* Compound Annual Growth Rate

Here are more details on the Cipla share price and the ALEMBIC share price.

Moving on to shareholding structures...

The promoters of Cipla hold a 33.5% stake in the company. In case of ALEMBIC the stake stands at 70.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Cipla and the shareholding pattern of ALEMBIC.

Finally, a word on dividends...

In the most recent financial year, Cipla paid a dividend of Rs 8.5 per share. This amounted to a Dividend Payout ratio of 24.2%.

ALEMBIC paid Rs 2.2, and its dividend payout ratio stood at 70.1%.

You may visit here to review the dividend history of Cipla, and the dividend history of ALEMBIC.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.